Home › Companies › Longboard Pharmaceuticals Inc.

Longboard Pharmaceuticals Inc. proxy voting records

How asset managers voted at Longboard Pharmaceuticals Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• CUSIP issuer number54300N
• SEC CIK1832168

Recent shareholder votes

• May 23, 2024 annual meeting (2023-2024 proxy season): 4 items in Longboard Pharmaceuticals Inc.'s official results (Form 8-K, filed May 24, 2024); lowest support 23% of votes cast (Elect Director: Paul J. Sekhri). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Earlier seasons list this company under the name LONGBOARD PHARMACEUTICALS INC., as its holders filed it.

Explore Longboard Pharmaceuticals Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built November 9, 2026.